An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.Brendan McDermid | ReutersAll doses of Eli…
Federal Trade Commission Chair Lina Khan testifies during a hearing of the House Appropriations Subcommittee on Financial Services and General Government, May 15, 2024.Tom Williams |…
Shares of Walgreens closed more than 20% lower on Thursday after the company reported fiscal third-quarter earnings that fell short of expectations and slashed its full-year…
Novo Nordisk’s new manufacturing facility in Clayton, North Carolina.Courtesy: Novo NordiskNovo Nordisk on Monday said it will spend $4.1 billion to build a new manufacturing plant…
Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most common sleep-related breathing disorder and expects…
Zoom In IconArrows pointing outwardsMerck’s new pneumococcal vaccine. Courtesy: MerckThe Food and Drug Administration on Monday approved Merck’s new vaccine designed to protect adults from a…
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.Hannah Mckay | ReutersThe Food and Drug Administration on Friday expanded the approval of GSK’s respiratory…
The FDA has approved Moderna’s RSV vaccine for older adults.Courtesy: ModernaThe Food and Drug Administration on Friday approved Moderna’s vaccine for respiratory syncytial virus for adults…
A top exchange-traded fund provider is betting on the long-term popularity of GLP-1 weight loss drugs.Roundhill Investments’ GLP-1 & Weight Loss ETF (OZEM), which began trading…
Amgen’s stock rose more than 12% on Friday after the drugmaker teased positive initial data on its experimental weight loss injection. That fueled investor concerns about new…